Menu
GeneBe

EPB41

erythrocyte membrane protein band 4.1, the group of FERM domain containing|Erythrocyte membrane protein band 4.1

Basic information

Region (hg38): 1:28887090-29120046

Previous symbols: [ "EL1" ]

Links

ENSG00000159023NCBI:2035OMIM:130500HGNC:3377Uniprot:P11171AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary elliptocytosis (Supportive), mode of inheritance: AD
  • elliptocytosis 1 (Strong), mode of inheritance: AD
  • elliptocytosis 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ellipsocytosis 1ARHematologicThe recessive form is more severe, and due to anemia, individuals may require transfusions, and/or splenectomyHematologic5731934; 7255153; 6894932; 7082842; 3965051; 3995181; 3755799; 3748797; 3674005; 1430200; 16730867; 14692233; 21839655

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EPB41 gene.

  • not provided (3 variants)
  • EPB41-related disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPB41 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
16
clinvar
4
clinvar
22
missense
62
clinvar
6
clinvar
1
clinvar
69
nonsense
3
clinvar
5
clinvar
8
start loss
1
clinvar
1
frameshift
1
clinvar
4
clinvar
1
clinvar
6
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
2
1
3
non coding
4
clinvar
6
clinvar
12
clinvar
22
Total 4 12 70 28 17

Variants in EPB41

This is a list of pathogenic ClinVar variants found in the EPB41 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-28987182-C-A Benign (Nov 11, 2018)1290643
1-28987461-G-A Elliptocytosis 1 • EPB41-related disorder Benign (Jan 18, 2024)811014
1-28987470-C-G Likely benign (Jan 01, 2023)2638582
1-28987471-G-A Uncertain significance (Oct 11, 2022)2683705
1-28987550-C-G Uncertain significance (Mar 10, 2022)1961095
1-28987557-A-G Elliptocytosis 1 • EPB41-related disorder Benign (Nov 23, 2023)994251
1-28987609-G-A Elliptocytosis 1 Conflicting classifications of pathogenicity (Nov 14, 2023)2683706
1-28987657-T-C Uncertain significance (-)1048987
1-28987689-C-G Uncertain significance (Sep 25, 2023)2983773
1-28987692-G-A EPB41-related disorder Likely benign (Feb 16, 2021)3046789
1-28987700-A-G Elliptocytosis 1 Conflicting classifications of pathogenicity (Sep 27, 2023)2428563
1-28987790-T-A Elliptocytosis 1 Uncertain significance (Aug 31, 2023)2920823
1-28987852-C-T Elliptocytosis 1 Uncertain significance (-)2585056
1-28987863-C-T Elliptocytosis 1 Likely benign (Oct 17, 2021)1330438
1-28987864-C-G Uncertain significance (May 24, 2021)1326496
1-28987909-A-T Uncertain significance (Sep 01, 2023)2638583
1-28993376-AAGG-A Uncertain significance (Apr 10, 2023)2974016
1-28993390-G-A Likely benign (Aug 19, 2022)1900971
1-28993408-G-C Uncertain significance (Sep 26, 2022)1302260
1-28993427-CT-C Uncertain significance (Sep 09, 2022)2683707
1-28993489-A-G Pathogenic/Likely pathogenic (Dec 12, 2019)618091
1-28993490-T-C Elliptocytosis 1 Pathogenic (Jan 01, 1995)16715
1-28993490-T-G Elliptocytosis 1 Pathogenic (Nov 01, 1992)16714
1-28993496-G-A Uncertain significance (Oct 12, 2020)1302938
1-28993500-G-A Likely benign (Sep 27, 2023)2726408

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EPB41protein_codingprotein_codingENST00000343067 19232951
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00003591.001256950531257480.000211
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9224064620.8790.00002525670
Missense in Polyphen210267.850.784023173
Synonymous0.2761601650.9730.000009261625
Loss of Function4.251749.10.3460.00000263602

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004740.000474
Ashkenazi Jewish0.000.00
East Asian0.0002180.000217
Finnish0.0003230.000323
European (Non-Finnish)0.0001670.000167
Middle Eastern0.0002180.000217
South Asian0.0002610.000261
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Protein 4.1 is a major structural element of the erythrocyte membrane skeleton. It plays a key role in regulating membrane physical properties of mechanical stability and deformability by stabilizing spectrin-actin interaction. Recruits DLG1 to membranes. Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}.;
Disease
DISEASE: Elliptocytosis 1 (EL1) [MIM:611804]: A Rhesus-linked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:3467321}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Splicing factor NOVA regulated synaptic proteins;Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses;Syndecan-2-mediated signaling events (Consensus)

Recessive Scores

pRec
0.359

Intolerance Scores

loftool
0.0367
rvis_EVS
-0.6
rvis_percentile_EVS
18.19

Haploinsufficiency Scores

pHI
0.757
hipred
Y
hipred_score
0.744
ghis
0.494

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.945

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Epb41
Phenotype
renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
epb41b
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
increased fragility

Gene ontology

Biological process
cell cycle;regulation of cell shape;actin cytoskeleton organization;cortical actin cytoskeleton organization;actomyosin structure organization;positive regulation of protein binding;cell division;protein-containing complex assembly;positive regulation of protein localization to cell cortex
Cellular component
nucleus;cytosol;plasma membrane;cytoplasmic side of plasma membrane;postsynaptic density;spectrin-associated cytoskeleton;cell junction;cortical cytoskeleton;protein-containing complex;cell cortex region
Molecular function
actin binding;structural constituent of cytoskeleton;protein binding;calmodulin binding;1-phosphatidylinositol binding;protein C-terminus binding;spectrin binding;protein N-terminus binding;phosphoprotein binding